Sessions

Gyrocardiography motion sensor technology, that can be operated on smartphones with no additional hardware required, has been validated for numerous heart diseases such heart failure, aortic stenosis, atrial fibrillation and pulmonary hypertension. The talk will focus on the scientific evidence from numerous clinical studies and demonstrating clinical utility in several use cases.

How can we improve care and make it more equal through a better and more efficient use of health data? This session, organized by Novartis and EU project EDAH will cover perspectives from patients, caregivers, and regions.Future opportunities and challenges with an increased use of health data will be addressed as well as what message to bring to the ongoing policy work within EHDS from the different user’s perspective.

Digital healthcare technologies (DTHs), including health apps, have brought with them a great potential to further develop healthcare services, but their introduction should follow the same criteria as other healthcare methods. The health technology assessment (HTA) supports decision-makers by producing the unbiased assessments of different type of health technologies. In Finland, the Digi-HTA process supports HTA activities for all types of DHTs, such as health apps, artificial intelligence and robotic solutions. In order to ensure that Digi-HTA would be as compatible as possible with other recognized assessment methods, the Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) has carried out a comparison work that includes the DiGA and NordDEC assessment models and the CEN/ISO TS 82304-2:2021 technical specification.

Lifestyle caused diseases are rapidly increasing and traditional ways of lifestyle guidance in healthcare are highly resource demanding and lacking effectiveness. Healthy Days is the solution which makes preventional care scalable with no resource limitations and lifts the patient on top of selfcare with proven effectiveness.

Women have been historically excluded from healthcare research and women’s health issues still receive inadequate attention, yet women live more years in poor health and with disability.Digital transformation and a rapidly growing global FemTech market provide new opportunities to transform the lives of millions of women globally and contribute to a substantial social impact and economic gains. However, research on FemTech that provide robust evidence on its value is lacking.In this seminar, based on our ongoing research, we will discuss opportunities and challenges of FemTech and why a rigorous research agenda with targeted research funding is needed. We will also address research methods that include multi-stakeholder partnerships, methods of intersectionality research to address health inequities, and co-creation models to engage women in the co-design of technologies to ensure person-centered outcomes.

Why is AI proving more of a challenge in Healthcare than other industries?  AI has been promoted as the saviour of medicine yet has failed to make the difference many predicted. Here in this presentation we will explore how AI has changed the potential for healthcare and the barriers that are still faced.

Remote Patient Monitoring is a crucial tool to create benefits for the patients, the providers and the payer. Yet there are several barriers on an international level that prevents the wider use of the technology, where reimbursement is still one of them. Boston Scientific has worked together with KOL's, patient organizations as well as trade organizations in trying to help solve the reimbursement. Our Health Economy and Market Access (HEMA) department acrosss Europe has managed be a valued partner in the development of reimbursement guidelines for RPM. Please join us in sharing our journey and our insights.

Despite years of work from both informaticians and IT-architects interoperability within healthcare is still low. This explorative case study performed on a well-staffed public health care provider shows that the involved roles were unclear, processes did not include each other, and that tooling was incompatible.However, interest in collaboration was high and technical advances and inhouse development were seen as incentives for increased collaboration.

Artificial intelligence (AI) has great potential to transform healthcare, making it more efficient, equitable, and safe. There are hundreds of AI-based tools available on the market today, yet few get adopted into clinical practice because of numerous barriers and challenges. This talk provides an overview of these hurdles and suggests 26 considerations synthesized from the literature, interviews, and workshop with stakeholders who have experience with the process of trying to adopt AI-based tools into clinical practice. We believe that as the barriers and challenges to AI adoption are addressed and overcome, AI will inevitably have a lasting impact on improving healthcare for all.

With an already existing pathway for digital therapeutics (DTx) and a new permanent reimbursement mechanism for remote monitoring, France is becoming the country with the most advanced reimbursement system for digital health. This presentation will give an overview of what these new pathways entail.